- Home
- Applications
- cancer detection
Refine by
Cancer Detection Product Applications
13 applications found
Cancer-targeted molecular probes have the potential to revolutionize surgery and diagnostics. ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
The Promise: With modern diagnostic and imaging technologies, cancer can be detected earlier than ever before. And with earlier detection comes the promise of a surgical cure—that is, the complete removal (or resection) of all tumor tissue from a patient. ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
We are collaborating with leading hospitals, integrated health systems, medical centers and biobanks around the world to conduct studies in order to further develop and validate UDX's blood test for early cancer ...
ByUniversal Diagnostics SL based in Seville, SPAIN
Pegloprastide (also known as AVB-620) has completed a Phase 2 registration trial for fluorescent detection of cancer during breast cancer surgery (NCT03113825), as well as a Phase 1b clinical trial in women undergoing breast cancer surgery ...
ByAvelas Biosciences based in La Jolla, CALIFORNIA (USA)
Advances in diagnostic methods have enabled the detection of cancer at the earliest stages when the chances for successful intervention are highest. ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
Multiplexing is the ability to identify a broad spectrum of conditions in a single molecular diagnostic test procedure, as opposed to conducting discrete individual procedures. It enables a single test to identify numerous conditions, attributes, or genetic sequences simultaneously, including those belonging to: cancer genes; a bacteria or virus in humans, animals or the food distribution supply chain, or specific attributes of a seed ...
ByCo-Diagnostics, Inc. based in Salt Lake City, UTAH (USA)
Versatile blood research tool: Hemostasis monitoring of newly emerged anticoagulants especially during cardiac surgeries poses more and more challenges to standard diagnostic instrumentations. 3T developers have made pioneering contributions in QCM-D technology for the analysis of health-related whole blood parameters (Oberfrank et al, 2016; Sinn et al, 2011; 2010; Müller et al, 2010). Now the qCell T series provides a sophisticated platform with outstanding potential to face such challenging situations due ...
By3T Analytik GmbH & Co. KG based in Neuhausen ob Eck, GERMANY
Refined Laser Systems has developed an innovative technology aimed at revolutionizing cancer diagnosis through stain-free and section-free histology. This advanced system operates via a molecular-specific microscope, eliminating the need for traditional, time-consuming staining and sectioning procedures. It is capable of producing Hematoxylin and Eosin (H&E) equivalent contrast images from freshly excised thick tissue specimens within minutes. This significantly reduces the time required for reliable ...
ByRefined Laser Systems GmbH based in Münster, GERMANY
As a diagnostic imaging tool, Breast MRI is used for a wide range of indications in breast disease management ...
ByAurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA)
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
Standard Biopsy Limitations Traditionally, men suspected of prostate cancer undergo systematic biopsies guided by ultrasound imaging. Because ultrasound offers poor cancer visualization, 12 random samples are taken without knowing if there is cancer and if so, where it is. As a result, the cancer is either missed entirely, or if detected, is difficult to determine the extent and severity. ...
ByFocal Healthcare based in Toronto, ONTARIO (CANADA)
They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune response in order to fully engage and fight tumor ...
ByKiadis Pharma NV based in Amsterdam, NETHERLANDS
SNAQ-SEQ ctDNA spike-in standards Liquid biopsies offer the promise of earlier detection and monitoring of cancer patients’ treatment progression. However, as applications increasingly rely on ultra low variant allele frequency detection, NGS-based assays are beset with significantly more noise below 0.5% VAF that increases the rate of false positives. Laboratories looking to implement ctDNA assays need better quality controls that can ensure accurate ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)